Trial design
This study was a double-blind randomized placebo-controlled two-period crossover clinical trial to assess cognitive performance after the administration of a chewable BR-based supplement. The neuropsychological testing battery was applied at the end of each period. The experimental procedures were conducted following those established in the extension of the Consolidated Standards of Reporting Trials (CONSORT) for randomized crossover trials [Schematic representation of the study design. 